rs5743274
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001370466.1(NOD2):c.1372C>T(p.Leu458Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,613,734 control chromosomes in the GnomAD database, including 46 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0095 ( 27 hom., cov: 33)
Exomes 𝑓: 0.00093 ( 19 hom. )
Consequence
NOD2
NM_001370466.1 synonymous
NM_001370466.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.73
Publications
2 publications found
Genes affected
NOD2 (HGNC:5331): (nucleotide binding oligomerization domain containing 2) This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
NOD2 Gene-Disease associations (from GenCC):
- Blau syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, G2P, Illumina, Labcorp Genetics (formerly Invitae)
- inflammatory bowel disease 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 16-50711364-C-T is Benign according to our data. Variant chr16-50711364-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 462696.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.73 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00947 (1442/152344) while in subpopulation AFR AF = 0.0332 (1379/41568). AF 95% confidence interval is 0.0317. There are 27 homozygotes in GnomAd4. There are 645 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1442 AD,Unknown gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NOD2 | NM_001370466.1 | c.1372C>T | p.Leu458Leu | synonymous_variant | Exon 4 of 12 | ENST00000647318.2 | NP_001357395.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NOD2 | ENST00000647318.2 | c.1372C>T | p.Leu458Leu | synonymous_variant | Exon 4 of 12 | NM_001370466.1 | ENSP00000495993.1 | |||
| NOD2 | ENST00000300589.6 | c.1453C>T | p.Leu485Leu | synonymous_variant | Exon 4 of 12 | 1 | ENSP00000300589.2 | |||
| NOD2 | ENST00000641284.2 | n.1372C>T | non_coding_transcript_exon_variant | Exon 4 of 6 | ENSP00000493088.1 | |||||
| NOD2 | ENST00000646677.2 | n.1372C>T | non_coding_transcript_exon_variant | Exon 4 of 13 | ENSP00000496533.1 |
Frequencies
GnomAD3 genomes AF: 0.00946 AC: 1440AN: 152226Hom.: 27 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1440
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00233 AC: 583AN: 250206 AF XY: 0.00170 show subpopulations
GnomAD2 exomes
AF:
AC:
583
AN:
250206
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000931 AC: 1361AN: 1461390Hom.: 19 Cov.: 34 AF XY: 0.000799 AC XY: 581AN XY: 727000 show subpopulations
GnomAD4 exome
AF:
AC:
1361
AN:
1461390
Hom.:
Cov.:
34
AF XY:
AC XY:
581
AN XY:
727000
show subpopulations
African (AFR)
AF:
AC:
1135
AN:
33480
American (AMR)
AF:
AC:
82
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
5
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
52920
Middle Eastern (MID)
AF:
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
17
AN:
1112010
Other (OTH)
AF:
AC:
117
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
92
183
275
366
458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00947 AC: 1442AN: 152344Hom.: 27 Cov.: 33 AF XY: 0.00866 AC XY: 645AN XY: 74502 show subpopulations
GnomAD4 genome
AF:
AC:
1442
AN:
152344
Hom.:
Cov.:
33
AF XY:
AC XY:
645
AN XY:
74502
show subpopulations
African (AFR)
AF:
AC:
1379
AN:
41568
American (AMR)
AF:
AC:
39
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4
AN:
68036
Other (OTH)
AF:
AC:
20
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
69
138
208
277
346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Sep 23, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Regional enteritis;C5201146:Blau syndrome Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autoinflammatory syndrome Benign:1
Mar 04, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.